ChromaDex Corporation (CDXC) Dividend History

ChromaDex Corporation (CDXC) is a nutritional science company known for its development and commercialization of proprietary antioxidants and ingredients. The company focuses on research, scientific validation, and supply of dietary supplements, functional foods, and beverages, with a strong emphasis on scientific integrity and innovation in the wellness industry.

10900 Wilshire Blvd, Los Angeles, CA, 90024
Phone: 310-388-6706
Website: https://www.chromadex.com

Dividend History

ChromaDex Corporation currently does not pay dividends

Company News

  • The chlorinated isopropane market is expected to grow at a CAGR of 4.9% from 2025 to 2035, driven by increasing demand from the pharmaceutical and agrochemical industries. The market is projected to reach $496 million by 2035.

    GlobeNewswire Inc.
    Featured Companies: ABOS
  • ChromaDex (CDXC) rises 12% as the FDA grants the Orphan Drug Designation and the Rare Pediatric Disease Designation to its investigational candidate, NRC, to treat ataxia telangiectasia.

    Zacks Investment Research
    Featured Companies: ALXO ANVS CGEN
  • Gainers Unique Fabricating, Inc. (NYSE: UFAB) jumped 56.3% to close at $0.8205 on Tuesday. Unique Fabricating posted a Q3 loss of $0.90 per share after the closing bell on Tuesday. TaskUs, Inc. (NASDAQ: TASK) shares jumped 37.2% to settle at $22.01 on Tuesday after the company reported better-than-expected Q3 results. The company also issued Q4 and FY22 sales guidance above analyst estimates. GrowGeneration Corp. (NASDAQ: GRWG) shares jumped 35.1% to close at $4.47 after the company reported better-than-expected Q3 sales. SkyWater Technology, Inc. (NASDAQ: SKYT) gained 31.6% to close at $11.37 after the company reported better-than-expected Q3 EPS and sales results. Groupon, Inc. (NASDAQ: GRPN) gained 27.4% to settle at $8.97 following Q3 results. Oportun Financial Corporation (NASDAQ: OPRT) climbed 26.8% to close at $5.26 after the company announced upbeat Q3 results. National CineMedia, Inc. (NASDAQ: NCMI) gained 26.2% to settle at $0.5451 after the company reported Q3 results. NeoGenomics, Inc. (NASDAQ: NEO) jumped 25.4% to close at $8.90 following better-than-expected Q3 results. Adaptimmune Therapeutics plc (NASDAQ: ADAP) gained 25.3% to settle at $2.08 following strong quarterly sales. Arqit Quantum Inc. (NASDAQ: ARQQ) jumped 25% to close at $10.26. Gaia, Inc. (NASDAQ: GAIA) gained 24.5% to close at $2.85 following Q3 results. LivePerson, Inc. (NASDAQ: LPSN) rose 24.2% to close at $12.57 after the company reported better-than-expected Q3 EPS and sales results. The company also issued FY22 sales guidance above analyst estimates. OmniAb, Inc. (NASDAQ: OABI) jumped 22.6% to close at $2.50. International Game Technology PLC (NYSE: IGT) gained 22.4% to close at $24.41. International Game Technology reported third-quarter FY22 revenue growth of 14% year-on-year to $1.06 billion (at constant currency), beating the consensus of $1.01 billion. Hims & Hers Health, Inc. (NYSE: HIMS) gained 19.7% to close at $5.53 after the company reported better-than-expected Q3 results. The company also issued Q4 and FY22 sales guidance above analyst estimates. SolarEdge Technologies, Inc. (NASDAQ: SEDG) climbed 19.1% to close at $251.73 after the company reported better-than-expected Q3 sales results and issued Q4 sales guidance with a midpoint above analyst estimates.. Ocuphire Pharma, Inc. (NASDAQ: OCUP) shares gained 19.1% to close at $2.49. Ocuphire Pharma entered into a global license agreement for development and commercialization of Nyxol Eye Drops for reversal of mydriasis, presbyopia and night vision disturbances. eHealth, Inc. (NASDAQ: EHTH) climbed 18.9% to close at $3.78 following strong Q3 results. Oncolytics Biotech Inc. (NASDAQ: ONCY) gained 18.7% to settle at $1.78. First Advantage Corporation (NASDAQ: FA) climbed 18.6% to close at $12.30 following Q3 results. Triumph Group, Inc. (NYSE: TGI) jumped 17.7% to settle at $11.19 after the company reported upbeat quarterly sales and raised FY23 earnings guidance. CTI BioPharma Corp. (NASDAQ: CTIC) gained 16.9% to close at $5.81 after the company reported better-than-expected Q3 EPS and sales results. Tactile Systems Technology, Inc. (NASDAQ: TCMD) jumped 16.8% to settle at $8.13 following strong Q3 sales. Oak Street Health, Inc. (NYSE: OSH) rose 16.2% to settle at $21.69 after the company reported better-than-expected Q3 EPS and sales results. Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) gained 16.1% to close at $3.89 following Q3 results. Fangdd Network Group Ltd. (NASDAQ: DUO) rose 15.6% to settle at $1.56. Allakos Inc. (NASDAQ: ALLK) climbed 15.5% to close at $7.07 following a narrower-than-expected Q3 loss. Reata Pharmaceuticals, Inc. (NASDAQ: RETA) gained 15.4% to close at $40.29 following Q3 results. Five9, Inc. (NASDAQ: FIVN) jumped 15.1% to close at $54.10 following Q3 results. AAON, Inc. (NASDAQ: AAON) jumped 14% to close at $74.75 following upbeat Q3 results. Rover Group, Inc. (NASDAQ: ROVR) gained 13.6% to close ...

    Benzinga
  • Investing.com
    Featured Companies: CGC CRON TLRY
  • CDXC earnings call for the period ending September 30, 2021.

    The Motley Fool
Page data last updated 07/25/2025 01:23:55 UTC